文献速递糖尿病肥胖与代谢综合征

2型糖尿病对美国实体器官移植结局的影响:来自国家登记处的数据

Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry.
PubMed 文献 · Diabetes Care · 2023-01-01

研究利用2006至2021年美国器官移植受者科学登记处数据,纳入462692例肺、心脏、肝、肾移植受者,分析移植前2型糖尿病对移植后死亡率的影响。结果显示移植前2型糖尿病患病率随时间上升,且与移植后死亡率独立相关,以肾移植最为显著。

要点

  • 移植前2型糖尿病患病率:肺15%、心脏26%、肝25%、肾30%,且随时间增加。
  • 移植前2型糖尿病与移植后死亡率独立相关,校正混杂因素后肾移植风险比最高(1.65)。
  • 各器官移植中,合并2型糖尿病者移植后死亡率均显著高于无2型糖尿病者。

核心结论

  • 实体器官移植候选者中2型糖尿病患病率不断上升,移植前2型糖尿病与移植后死亡率独立相关,以肾移植最为显著。

研究设计与样本

  • 回顾性队列研究,使用2006至2021年美国器官移植受者科学登记处数据,纳入所有年龄≥18岁接受肺、心脏、肝或肾移植的患者。

主要发现

  • 共纳入462692例实体器官移植受者:肺移植31503例、心脏移植38004例、肝移植106639例、肾移植286440例。
  • 移植前2型糖尿病患病率:肺15%、心脏26%、肝25%、肾30%,且随时间增加。
  • 合并2型糖尿病者移植后死亡率显著高于无2型糖尿病者:肺移植3年32.1% vs 29.3%、5年46.4% vs 42.6%(P<0.01);心脏移植1年11.2% vs 9.1%、5年24.4% vs 20.6%(P<0.0001);肝移植1年10.6% vs 8.9%、5年26.2% vs 22.0%(P<0.0001);肾移植1年5.3% vs 2.5%、5年20.8% vs 10.1%(P<0.0001)。
  • 校正临床人口学混杂因素后,移植前2型糖尿病与移植后死亡率升高的独立关联显著:肺移植校正风险比1.08(95%CI 1.03-1.13)、心脏1.26(1.20-1.32)、肝1.25(1.21-1.28)、肾1.65(1.62-1.68),P<0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes (T2D) is a major driver of chronic diseases around the globe. The aim was to assess the impact of T2D on the outcomes of solid organ transplantations. RESEARCH DESIGN AND METHODS: We used the Scientific Registry of Transplant Recipients from 2006 to 2021 to collect data for all patients age ≥18 years who received a lung, heart, liver, or kidney transplant in the U.S. RESULTS: We included 462,692 solid organ transplant recipients: 31,503 lung, 38,004 heart, 106,639 liver, and 286,440 kidney transplantations. The prevalence of pretransplantation T2D was 15% in lung, 26% in heart, 25% in liver, and 30% in kidney transplant recipients, increasing over time. Posttransplantation mortality was significantly higher among transplant recipients with T2D versus those without T2D (lung 32.1% vs. 29.3% [3 years], 46.4% vs. 42.6% [5 years]; P < 0.01; heart 11.2% vs. 9.1% [1 year], 24.4% vs. 20.6% [5 years]; P < 0.0001; liver 10.6% vs. 8.9% [1 year], 26.2% vs. 22.0% [5 years]; P < 0.0001; kidney 5.3% vs. 2.5% [1 year], 20.8% vs. 10.1% [5 years]; P < 0.0001). Independent association of pretransplantation T2D with higher posttransplantation mortality was significant after adjustment for clinicodemographic confounders (adjusted hazard ratio in lung transplant recipients 1.08 [95% CI 1.03-1.13]; heart 1.26 [1.20-1.32]; liver 1.25 [1.21-1.28]; kidney 1.65 [1.62-1.68]; P < 0.01). CONCLUSIONS: The prevalence of T2D in solid organ transplantation candidates is increasing. In all solid organ transplantations, pretransplantation T2D was independently associated with higher posttransplantation mortality, most profoundly in kidney transplantations.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Stepanova M, Kumar A, Brandt P, et al. Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry. Diabetes Care. 2023. PMID: 37748128. doi:10.2337/dc23-1085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。